Hjem › Osteosarkom › Tennessee
Osteosarkom kliniske forsøg i Tennessee
12 studier for Osteosarkom søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Saint Jude Children's Research Hospital, Memphis
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 29. sep. 2026 · NCT04616560Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
RekruttererFase 1/2
Op til 26 år · Alle køn · Opdateret 3. sep. 2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
RekruttererFase 1/2
Op til 30 år · Alle køn · Opdateret 3. sep. 2026 · NCT06541262Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
- St. Jude Children's Research Hospital, Memphis
RekruttererFase 2
Op til 21 år · Alle køn · Opdateret 1. sep. 2026 · NCT07428993Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- og 1 flere
RekruttererFase 3
Op til 50 år · Alle køn · Opdateret 25. aug. 2026 · NCT05235165Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Saint Jude Children's Research Hospital, Memphis
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
- St. Jude Children's Research Hospital, Memphis
Rekrutterer
Alle aldre · Alle køn · Opdateret 21. aug. 2026 · NCT07514819NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- St. Jude Children's Research Hospital, Memphis
RekruttererFase 1/2
Op til 30 år · Alle køn · Opdateret 3. aug. 2026 · NCT06239272Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
- St. Jude Children's Research Hospital, Memphis
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 5 til 20 · Alle køn · Opdateret 18. jun. 2026 · NCT07502885B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
- St. Jude Children's Research Hospital, Memphis
RekruttererFase 1
Op til 21 år · Alle køn · Opdateret 19. maj 2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- St. Jude Children's Research Hospital, Memphis
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 19. maj 2026 · NCT04901702Molecular Analysis Of Solid Tumors
- St. Jude Children's Research Hospital, Memphis
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 12. nov. 2025 · NCT01050296Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.